Form 4: Abeona Therapeutics SVP, General Counsel Brendan O'Malley Reports Stock Transaction
SEC Form 4 Filing
Brendan O'Malley, SVP and General Counsel of Abeona Therapeutics, reports the disposition of 92 shares of common stock to cover tax obligations upon vesting of restricted stock on March 31, 2024.
Summary
- On March 31, 2024, Brendan O'Malley, the SVP and General Counsel of Abeona Therapeutics, disposed of 92 shares of common stock.
- The shares were surrendered to satisfy tax withholding obligations related to the vesting of restricted stock.
- The transaction was executed at a price of $7.25 per share.
- Following the transaction, O'Malley directly owns 180,026 shares of Abeona Therapeutics common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing represents a routine transaction for tax purposes and doesn't necessarily indicate a change in the executive's confidence in the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of stock transaction (disposition of shares). |
| 06/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.